Company
Achira
Achira is building molecular world models to power the future of drug design and the physical sciences.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- drug discovery scientist interested in partnering with us
Record updated 18 September 2026
About
Achira is creating a new class of molecular world models that blend geometric deep learning, generative AI, physics, quantum chemistry, and statistical mechanics into advanced foundation simulation models and generative models to deliver unprecedented performance across a diverse set of biomolecular applications, transforming drug discovery and downstream materials design into true inverse design problems by learning to program matter.
Funding snapshot
- Total raised
- $33MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Undisclosed, $33M
Funding rounds
- Round
- $33MCompany stated